G. Perry

The European Generic Pharmaceutical Market in Review: 2006 and Beyond

G. Perry, 2006 .

Impact of Neostigmine and Sugammadex on Time to Leaving the Operating Room in a Community Hospital

R. Hall, J. Raza, G. Perry, 2020, Innovations in pharmacy.

Pharmacokinetics of rufloxacin in patients with impaired renal function

B. Imbimbo, R. Wise, T. Mant, 1993, Antimicrobial Agents and Chemotherapy.

Affordability of new HIV treatments

E. Burrone, G. Perry, 2014, The Lancet.

Ensuring new medicines reach those in most need.

E. Burrone, G. Perry, 2015, The lancet. HIV.

scale-up can benefi t from the best medicines available. This is one path to sustaining today's treatment gains and to meeting future goals for eradication.

E. Burrone, G. Perry, 2015 .

Peer Recovery Provides Sustainable Avenues for Addiction Treatment, but Is Not a One-Size-Fits-All Proposition

T. Davies, G. Perry, Heather M. Bucur, 2020 .

Tuberculosis and antimicrobial resistance – new models of research and development needed

M. P. Matsoso, M. Spigelman, G. Gray, 2017, Bulletin of the World Health Organization.